Top
Main

All Outcomes

Feedback
Home
Show Outline
Top   Main   All Outcomes
Home   COVID-19 treatment studies for Sleep  COVID-19 treatment studies for Sleep  C19 studies: Sleep  Sleep   Select treatmentSelect treatmentTreatmentsTreatments
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta
Lactoferrin Meta

Other Treatments Global Adoption
Loading...
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc
Supplementary Data — Sleep for COVID-19: real-time meta analysis of 12 studies
Covid Analysis, December 2022
https://c19early.org/slmeta.html
 
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Cloosterman 32% 0.68 [0.43-1.07] symp. case 31/201 222/2,385 Improvement, RR [CI] Treatment Control Gao 36% 0.64 [0.42-0.97] cases case control Holt 12% 0.88 [0.61-1.27] cases n/a n/a Holt 12% 0.88 [0.68-1.14] cases n/a n/a Holt 22% 0.78 [0.60-0.99] cases n/a n/a Marcus 16% 0.84 [0.76-0.93] symp. case n/a n/a Li 43% 0.57 [0.35-0.90] death n/a n/a Li 36% 0.64 [0.46-0.89] hosp. n/a n/a Li 21% 0.79 [0.64-0.96] hosp. n/a n/a Ahmadi 3% 0.97 [0.59-1.61] death 189/252,788 17/14,520 Mohsin 38% 0.62 [0.49-0.77] severe case 327/948 273/552 Huang 81% 0.19 [0.05-0.66] severe case 12/127 4/9 Kim 17% 0.83 [0.70-0.99] m/s case n/a n/a Kim 11% 0.89 [0.81-0.97] cases n/a n/a Paul 67% 0.33 [0.19-0.55] no recov. n/a n/a Paul 54% 0.46 [0.28-0.74] no recov. n/a n/a Jones 39% 0.61 [0.45-0.82] death n/a n/a Jones 32% 0.68 [0.56-0.82] hosp. n/a n/a Jones 7% 0.93 [0.86-1.00] cases n/a n/a Pływaczewska-J.. 17% 0.83 [0.68-1.01] m/s case 1,225 (n) 622 (n) Pływaczewska-J.. 7% 0.93 [0.73-1.16] PASC 1,015 (n) 502 (n) Sleep COVID-19 outcomes c19early.org/sl Dec 2022 Favors good sleep Favors control
Figure S1. All outcomes.
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit